MERIDIAN MEDICAL TECHNOLOGIES INC

Meridian Medical Technologies Inc. has long specialized in the development and manufacture of emergency-use pharmaceuticals and medical injectables, with a product line focused on rapid-response antidotes, antidote delivery systems, and critical-care drug products that support first responders, military units, and hospital emergency departments; its work fits into the broader SIC category of pharmaceutical preparations and emergency medical products, highlighting its role within the essential medical manufacturing industry. The company’s supply agreements and regulatory permits keep it tightly tied to federal programs such as the Strategic National Stockpile, which underscores an operating footprint sensitive to defense and public-health spending decisions, while compliance with FDA drug manufacturing regulations, the risk of reimbursement pressure, and dependence on single-source active pharmaceutical ingredients all remain material considerations. With the latest filing currently unknown, investors should still watch for disclosures tied to product approvals or government contracts; view live SEC filings on Earnings Feed for the freshest updates.

Source: Earnings Feed research · last updated 11/24/2025